NeuroPsyAI is a company co-founded, in 2017, as a spin-off of our lab, and Dr Hugo Ferreira’s lab, at Instituto de Biofísica e Engenharia Biomédica (IBEB-FCUL).
It has been awarded a series of prizes and distinctions, including the AI in Healthcare for Radiology Philips Acceleration Program 2018 selection (19 in 750 worldwide), an SME Instrument Phase I (Horizon 2020) Grant from the European Commission, and EIT Health Catapult 2nd Prize in Digital Health and EI Health Headstart award 2018 from the European Institute of Innovation & Technology, the Caixa Empreendedor 1st Prize 2018 from BPI and La Caixa, the Top 5 Distinction at AI Rising Stars 2018 competition by the Founders Factory London, the “Best of Portugal” 1st Prize in Software by the Exame Informática magazine, among others.
We partner with NeuroPsyAI, for the development of biomarkers for Parkinson’s and Alzheimer’s diseases. Find more in: www.neuropsycad.com.
You must be logged in to post a comment.